Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia

Effect of Ezetimib on metabolism and renal functions in CKD patients with dysglycemia and high LDL cholesteremia - Effect of Ezetimib on metabolic and renal functions

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002646

Enrollment

Registered

2009-10-19

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CKD patients with dysglycemia and high LDL choresterol

Interventions

Ezetimib

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: CKD with dysglycemia and high LDL choresteremia 1) LDL choresterol higher than 120 mg.dl 2) eGFR higher than 30ml.min.1.73m2

Exclusion criteria

Exclusion criteria: 1) HbA1c higher than 9 percent 2) Allergy to ezetimib 3) Severe hepatic disease 4) pregnancy and suckling 5) familial hyperchoresteremia

Design outcomes

Primary

Measure	Time frame
1) LDL choresterol 2) Achivement of target LDL choresterol	—

Countries

Japan

Contacts

Public ContactDaisuke Koya

Kanazawa Medical University Endocrinology & Metabolism

koya0516@kanazawa-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026